Scarica l'app Stockscreener
181.85
1.14%
-2.14
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DVA Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$183.99
Aprire:
$183.16
Volume 24 ore:
72,332
Relative Volume:
0.09
Capitalizzazione di mercato:
$11.61B
Reddito:
$13.84B
Utile/perdita netta:
$1.10B
Rapporto P/E:
17.45
EPS:
10.4185
Flusso di cassa netto:
$1.49B
1 W Prestazione:
+3.27%
1M Prestazione:
-1.02%
6M Prestazione:
+20.66%
1 anno Prestazione:
+35.23%
Intervallo 1D:
$181.45
$183.28
Intervallo di 1 settimana:
$176.43
$184.13
Portata 52W:
$101.00
$247.49
Davita Inc Stock (DVA) Company Profile
Nome
Davita Inc
Settore
Industria
Telefono
310-536-2668
Indirizzo
2000 16TH STREET, DENVER, CO
Compare DVA vs HCA, THC, FMS, EHC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
181.95 | 11.74B | 13.84B | 1.10B | 1.49B | 10.42 |
HCA
Hca Healthcare Inc
|
406.11 | 87.68B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
264.47 | 21.34B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
22.58 | 12.06B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
121.57 | 12.01B | 6.07B | 793.80M | 464.40M | 5.9914 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2023-08-07 | Aggiornamento | UBS | Neutral → Buy |
| 2022-11-01 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-10-31 | Downgrade | UBS | Buy → Neutral |
| 2022-08-19 | Ripresa | UBS | Buy |
| 2022-06-21 | Reiterato | BofA Securities | Underperform |
| 2021-09-10 | Iniziato | Cowen | Market Perform |
| 2021-08-12 | Downgrade | Barclays | Overweight → Equal Weight |
| 2021-03-26 | Downgrade | BofA Securities | Neutral → Underperform |
| 2021-01-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-01-24 | Aggiornamento | Goldman | Neutral → Buy |
| 2019-11-07 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | Aggiornamento | UBS | Sell → Neutral |
| 2019-01-03 | Iniziato | Deutsche Bank | Buy |
| 2018-12-14 | Iniziato | Barclays | Overweight |
| 2018-11-28 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | Iniziato | UBS | Sell |
| 2018-11-08 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2018-01-04 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2017-12-07 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | Downgrade | JP Morgan | Neutral → Underweight |
| 2017-06-26 | Downgrade | Jefferies | Buy → Hold |
| 2016-12-13 | Downgrade | Robert W. Baird | Outperform → Neutral |
Mostra tutto
Davita Inc Borsa (DVA) Ultime notizie
Commitment to Helping Communities Thrive: DaVita Community Care Report 2025 - ACCESS Newswire
DaVita Inc. stock holds near recent highs on solid Q2 2026 earnings and guidance - AD HOC NEWS
DaVita stock heads into the open after a flat prior close - AD HOC NEWS
DaVita Inc. stock gains support from solid Q2 2026 earnings - AD HOC NEWS
DaVita Inc. (DVA) Stock Analysis: Evaluating the 18.72% Upside Potential for Healthcare Investors - DirectorsTalk Interviews
DaVita Inc. stock gains on solid Q1 figures and buybacks - AD HOC NEWS
DaVita $15M Data Breach Settlement Hits 2.4M Patients - tech-insider.org
DaVita stock gains as Humana expands kidney care - AD HOC NEWS
Healthcare August recap: Moderna jumps 156% as biotech shines; DaVita sinks - Seeking Alpha
DaVita $15M Data Breach Settlement 2026: What It Pays - shattered.io
NewsDaVita to pay $15 million to settle data breach lawsuit affecting millions of dialysis patients - teiss
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now - easternprogress.com
DaVita Reaches Preliminary Settlement Class Agreement Following Ransomware Attack - Benzinga
DaVita (DVA) Has Investors Asking A Fresh Question - Yahoo Finance
DaVita Inc. stock gains support from higher earnings and steady guidance - AD HOC NEWS
DaVita (DVA) Q2 2026 Earnings Call Transcript - Fortune
DaVita agrees to pay $15M to settle claims from data breach - MedTech Dive
DaVita Inc. stock holds near 179 dollars after strong 2026 earnings momentum - AD HOC NEWS
Why Is DaVita HealthCare (DVA) Down 4.9% Since Last Earnings Report? - Yahoo Finance
Do Options Traders Know Something About DaVita Stock We Don't? - TradingView
DaVita Community Care Report 2025: Leading With Integrity and Accountability - CSRwire
DaVita Inc. stock gains after data breach settlement and partnership expansion - AD HOC NEWS
DaVita (NYSE:DVA): Is the Humana Deal Unlocking More Value? - Kalkine Media
DaVita stock trades around $180 as Q2 2026 growth and kidney-care partnership shape expectations - AD HOC NEWS
DaVita Inc. stock underperforms Monday when compared to competitors - MarketWatch
DaVita stock holds $180.72 as earnings beat and guidance stand out - AD HOC NEWS
Zacks Industry Outlook Highlights DaVita, LifeStance Health, Option Care Health, and Aveanna Healthcare - Yahoo Finance
DaVita Inc. (DVA) Stock Analysis: Strong EPS and Growth Potential Highlight Investment Opportunity - DirectorsTalk Interviews
At US$180, Is DaVita Inc. (NYSE:DVA) Worth Looking At Closely? - Moomoo
Will DaVita’s (DVA) Expanded Humana CKD Partnership Reshape Its Value-Based Care Narrative? - simplywall.st
Enterprise value to revenue forward of DaVita Inc. – NYSE:DVA - TradingView
Davita Inc. Announces New Value-Based Partnership with Humana Inc. to Expand Care for Patients with Chronic Kidney Disease - marketscreener.com
DaVita Defeats Nurse Overtime Collective Bid - Law360
DaVita, Patients Get Early Nod in $15 Million Data Breach Deal - Bloomberg Law News
DaVita dialysis clinic in Novi has repeated deficiencies as families demand answers after 2 deaths - WXYZ Channel 7
Wealthfront Advisers LLC Buys Shares of 10,596 DaVita Inc. $DVA - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Takes Position in DaVita Inc. $DVA - MarketBeat
Danske Bank A S Invests $13.11 Million in DaVita Inc. $DVA - MarketBeat
DaVita Inc. stock underperforms Thursday when compared to competitors - MarketWatch
DaVita stock steadies after Q2 revenue growth but EPS outlook disappoints - Ad-hoc-news.de
Patients Share Their Experiences With Expanded HD - DaVita Newsroom
DaVita (DVA) Financial Results: EPS Exceeds Its Estimate on the Day; Market Response: The Stock Loses 0.36%Strong Earnings Momentum - Vinanet
DaVita stock slips after Q2 revenue beats forecasts - Ad-hoc-news.de
DaVita (NYSE: DVA) reports new insider stock trade - Stock Titan
DaVita (NYSE: DVA) director Phyllis Yale gets 278-share stock award - Stock Titan
DaVita (NYSE: DVA) insider logs new stock trade in SEC filing - Stock Titan
DaVita (NYSE: DVA) director now holds 5,970 shares after award - Stock Titan
Forever Committed to Excellence in Care: DaVita Community Care Report 2025 - CSRwire
News by ACCESS Newswire on TradingView, 2026-08-18 - TradingView
DaVita Inc. (DVA) Stock Analysis: A Strong ROE And 21% Potential Upside - DirectorsTalk Interviews
Davita Inc Azioni (DVA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.35%
1.20%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):